Given that NLRP3 and IL1B gene expression in myeloid cells is strongly induced following NF-κB activation18,32, LPS priming is expected to enhance NLRP3 expression in cells from CAPS patients, yet mutant NLRP3 can constitutively assemble active inflammasomes. This evidence concerns the gene NFKB1 and cryopyrin-associated periodic syndrome.